Colon Cancer – Page 2 – PossibleThreat Articles

Breaking the stroma barrier: Study shows a new way to hit cancer with radiation

October 21, 2019 0 Comments Brain Tumor, Breast Cancer, Cancer, Colon Cancer, Lung Cancer, Pancreatic Cancer, Prostate Cancer, Skin Cancer

Chemotherapy and radiation therapy are commonly used to treat cancer, but are not always effective and can have toxic side effects. Researchers tested a new radiotherapy technique that sends alpha-emitting particles to stroma cells in pancreatic tumors. The method slowed tumor growth in mice with minimal side effects, pointing to a new potential treatment option in the future for patients with pancreatic cancer.

News Science

HPV immunization program cuts pre-cancer rates by more than half

October 21, 2019 0 Comments Breast Cancer, Cancer, Cervical Cancer, Colon Cancer, Men's Health, Skin Cancer, Vaccines, Women's Health

A school-based human papillomavirus (HPV) immunization program in British Columbia, Canada, is dramatically reducing rates of cervical pre-cancer in B.C. women, according to a new study.

News Science

Creatine powers T cells' fight against cancer

October 19, 2019 0 Comments Brain Tumor, Cancer, Colon Cancer, Immune System, Lung Cancer, Lymphoma, Skin Cancer, Stem Cells

The study, conducted in mice, is the first to show that creatine uptake is critical to the anti-tumor activities of killer T cells, the foot soldiers of the immune system.

News Science

New insights into the structure and function of Cdc34, a target for cancer therapeutics

October 17, 2019 0 Comments Brain Tumor, Breast Cancer, Cancer, Colon Cancer, Leukemia, Lung Cancer, Lymphoma, Pancreatic Cancer

Researchers report they have obtained 3D structural snapshots of Cdc34 in action. Cdc34 is an enzyme important for cell cycle regulation and a target for therapeutic intervention in cancer. These structures, along with studies in human cells, have revealed key features of this enzyme important for its regulation of cell growth and activity. These unique features could present opportunities for rational design of novel cancer therapeutics.

News Science

Digital breast tomosynthesis increases cancer detection over full-field mammography

October 17, 2019 0 Comments 3-D Printing, Breast Cancer, Cancer, Colon Cancer, Medical Technology, Pancreatic Cancer, technology

A new article compares cancer detection rates (CDR) for screening digital breast tomosynthesis (DBT) versus full-field digital mammography (FFDM). Researchers found that DBT results in 'significantly increased CDR' — irrespective of tumor type, size, or grade of cancer.

News Science

Exercise guidelines for cancer survivors

October 17, 2019 0 Comments Breast Cancer, Cancer, Colon Cancer, Diseases and Conditions, Fitness, Lung Cancer, Men's Health, Ovarian Cancer

For the rising number of cancer survivors worldwide, there's growing evidence that exercise is an important part of recovery. But how much, and what type of exercise, is needed?

News Science

Beyond Mutation: Cause of drug resistance in a type of intestinal tumors

October 17, 2019 0 Comments Brain Tumor, Breast Cancer, Cancer, Colon Cancer, Genes, Lung Cancer, Personalized Medicine, Prostate Cancer

Researchers clarify mechanisms that allow hard-to-treat cancers to develop, and have identified strategies that could lead to new therapies.

News Science

Pioneering cell therapies for non-responders to current immunotherapies

October 16, 2019 0 Comments Brain Tumor, Cancer, Colon Cancer, Diseases and Conditions, Immune System, Lung Cancer, Lymphoma, Skin Cancer

New research signposts a new, less invasive approach to identify killer T lymphocytes in patients with gastrointestinal tumors with low mutational burden who are refractory to approved immune-based treatments.

News Science

Progress in global cancer fight is not only possible, but achievable

October 16, 2019 0 Comments Brain Tumor, Breast Cancer, Cancer, Colon Cancer, Leukemia, Lung Cancer, Ovarian Cancer, Pancreatic Cancer

The Cancer Atlas, 3rd edition, a comprehensive global overview of cancer around the globe, concludes that progress in the fight against cancer is not only possible, but achievable.

News Science

Inactive receptor renders cancer immunotherapies ineffective

October 16, 2019 0 Comments Breast Cancer, Cancer, Colon Cancer, Diseases and Conditions, Immune System, Lung Cancer, Lymphoma, Skin Cancer

The aim of immunotherapies is to enable the immune system once again to fight cancer on its own. Drugs known as checkpoint inhibitors are already in clinical use for this purpose. However, they are only effective in about one third of patients. Based on analysis of human tissue samples, a team has now discovered one reason why this is so: an inactive receptor in cancer cells prevents the drugs from reactivating the immune system.